Regulation of Proliferation, Cell Fate Specification and Differentiation by the Homeodomain Proteins Prox1, Six3, and Chx10 in the Developing Retina
Overview
Authors
Affiliations
The coordination of proliferation and cell fate specification is of particular importance in the developing central nervous system, because different classes of neurons are generated at different stages of development. As a consequence, if too many or too few multipotent progenitor cells exit the cell cycle during the early stages of development, then a predictable shift in the ratio of neuronal cell types would occur. Such a perturbation could prove devastating for normal neural function. In the past several years, we have made numerous advances toward understanding the roles of cell cycle proteins in the development of the retina, a specialized region of the central nervous system. More recently, researchers have identified and characterized a number of homeodomain transcription factors that regulate the proliferation of retinal progenitor cells and the specification of cell fate. In this review, I will present recent findings about the homeodomain protein Prox1 and compare them with studies of two other homeodomain proteins that are important regulators of retinal development, Chx10 and Six3. Together, the research on the genes that encode these three proteins raises several new questions about the mechanisms underlying the coordination of proliferation and cell fate specification in the developing central nervous system.
Mutant kri1l causes abnormal retinal development via cell cycle arrest and apoptosis induction.
Zhang R, Sun J, Xie Y, Zhu W, Tao M, Chen Y Cell Death Discov. 2024; 10(1):251.
PMID: 38789412 PMC: 11126728. DOI: 10.1038/s41420-024-02022-2.
Mutation of genes in zebrafish highlights the robustness of the retinal specification network.
Letelier J, Buono L, Almuedo-Castillo M, Zang J, Mounieres C, Gonzalez-Diaz S Elife. 2023; 12.
PMID: 37227126 PMC: 10212559. DOI: 10.7554/eLife.85594.
Gamm D, Clark E, Capowski E, Singh R Am J Ophthalmol. 2019; 206:113-131.
PMID: 31078532 PMC: 6842420. DOI: 10.1016/j.ajo.2019.04.033.
Chen L, Zhang Y, Zhang Z, Huang T, Cai Y Mol Ther Methods Clin Dev. 2018; 10:57-67.
PMID: 30069494 PMC: 6068090. DOI: 10.1016/j.omtm.2018.06.007.
Zhao Y, Zheng D, Cvekl A Exp Eye Res. 2018; 175:56-72.
PMID: 29883638 PMC: 6167154. DOI: 10.1016/j.exer.2018.06.004.